Navigation Links
Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
Date:9/1/2010

SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the Company will present at the following investor conferences:

  • Robert W. Baird 2010 Health Care Conference on Tuesday, September 14, 2010 at 8:30 a.m. Eastern Time at The St. Regis Hotel in New York City.
  • UBS Global Life Sciences Conference 2010 on Tuesday, September 21, 2010 at 10:00 a.m. Eastern Time at the Grand Hyatt New York in New York City.
  • 5th Annual JMP Securities Healthcare Conference on Monday, September 27, 2010 at 9:00 a.m. Eastern Time at The New York Palace in New York City.

  • (Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

    (Logo:  http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

    Live audio webcasts of these presentations will be accessible on the Company's website at www.optimerpharma.com, under the investors section.  Replays of these presentations will be available at the same location for 30 days after the presentations.

    About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).  In two Phase 3 trials completed by Optimer to study the safety and efficacy of fidaxomicin for the treatment of CDI, fidaxomicin was statistically superior to vancomycin in global cure rate (defined as cure with no recurre
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
    2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
    3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
    4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
    5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
    6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
    7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
    8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/3/2015)...   Intarcia Therapeutics, Inc. today announced its ... Sessions of the American Diabetes Association taking place June ... the Boston Convention and Exhibition Center. The presentations span ... currently marketed and investigational therapies on patients with type ... late-stage clinical candidate, ITCA 650. , Saturday ...
    (Date:6/3/2015)... , June 02, 2015 Research ... addition of the "2015 Strategies in the ... their offering. Highlights of the Report ... the US tumor marker testing market. , ... as well as key economic, regulatory, demographic, social ...
    (Date:6/3/2015)... BARBARA, Calif. , June 3, 2015  The ... formal endorsement of a Midwife Kit as a standard ... Kit was developed by Direct Relief in consultation with ... of charge to midwives in developing countries. ... from complications related to their pregnancy or childbirth.  Skilled ...
    Breaking Medicine Technology:Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 2Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 3Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston 4United States Strategies in the Tumor Marker Testing Market 2015 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4
    (Date:6/3/2015)... Loma Linda University Health and Adventist Health ... Memorial Hospital (SGMH). The SGMH board voted unanimously to ... “Loma Linda University Health has been serving the Pass ... officer, Loma Linda University Medical Center. “We are thrilled ... this community.” , Under the proposed affiliation, Loma ...
    (Date:6/3/2015)... NY (PRWEB) June 03, 2015 Johnson ... to pay $7.8 million to resolve a Risperdal lawsuit ... over tactics the company allegedly used to market the ... Circuit Court indicate that the Arkansas Attorney General moved ... of the accord. The Risperdal settlement amounts to just ...
    (Date:6/3/2015)... 2015 The National Resident Matching Program ... C. Savoia, M.D., Dean of Medical Education at the University ... Chair on July 1. , “It is an ... Resident Matching Program,” said Dr. Savoia. “NRMP’s goal is ... medical students with training programs, and I welcome the opportunity ...
    (Date:6/3/2015)... On the heels of a report predicting ... ( click here to review news coverage about the ... has the talent to become a world-leading center of ... other biological data are collected and analyzed to help scientists ... the elements of a perfect storm for bioinformatics leadership,” said ...
    (Date:6/3/2015)... Jersey (PRWEB) June 03, 2015 Horizon Blue ... Diversity MBA Magazine as one of the nation’s top employers ... BCBSNJ No. 6 among its national list of Best Places ... BNCBSNJ as the No. 1 Regional Company. This is ... by Diversity MBA Magazine for its diverse workplace policies and ...
    Breaking Medicine News(10 mins):Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2
    ... Jan. 7 The following is a statement by ... of the State address put forth recommendations on a ... care and financial security of New Yorkers of all ... Family Health Plus Program to 200 percent of the ...
    ... Whether low levels would work for ER patients with ... -- Going to the world,s most elevated natural laboratory, ... medical rules about the amount of oxygen needed by ... people can tolerate extremely low levels of oxygen, much ...
    ... known as Emily,s Law, has received Governor Ted Strickland,s ... of Ohio. Named after Emily Jerry, Emily,s Law will ... law, which was originally sponsored by Senator Tim Grendell, ... Association. Emily,s Story , Emily Jerry died at ...
    ... Provide Support and Convenience CARLSBAD, Calif., Jan. 7 ... a new on-line service for physicians and patients ... products. The new Web site, www.skinmedica.com , ... while offering the convenience of on-line information and ...
    ... WESTCHESTER, Ill., Jan. 7 BrainLAB, Inc., ... medical treatments,announces a new, customer-focused sales and ... growth and an expanding product,portfolio. , ... and support structures, customers will benefit,from a ...
    ... AR, AZ, CO, FL, LA, NM and TXBOISE, Idaho, ... its Albertsons Rx-tra Savings prescription discount program ... a 90-day supply of over 500 generic drugs. ... its formulary of over 500 drugs that are already ...
    Cached Medicine News:Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2
    The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
    ... is the newest addition to the Primus ... the unbeatable combination of speed and accuracy ... or moderate volume testing. Test results in ... technology for the lab or clinic., ,The ...
    ... HbA1c Testing , Monoclonal antibody method ... , Correlation study shows 99% agreement with ... can count on a CV of ... National Glycohemoglobin Standardization Program (NGSP) certified method, ...
    ... M-4 is a manual hemostasis analyzer ... clotting assays - PTs, aPTTs, thrombins, ... easy, inexpensive, low-volume testing, this analyzer ... on features, offering time and labor ...
    Medicine Products: